Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi JPX-NIKKEI 400 UCITS ETF Daily Hedged GBP Acc

JPHG · LU1681039308 · class UCITS ETF Daily Hedged GBP Acc · GBP · domicile Luxembourg
Equity · JapanGBP-hedged share classSFDR art. 6
Index tracked: JPX-Nikkei 400 Net Total Return Daily GBP Hedged Index
TER
0.18%+ trans. 0.00%
Fund size
11 m EUR
Tracking difference
−0.43%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Accumulating
Launch 21 Mar 2018 · costs from the KID as of 2 Sept 2026 · 37 securities held · 4 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 7 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of JPX-Nikkei 400 Index, and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index : dividends net of tax paid by the index constituents are included in the Index return. JPX-Nikkei 400 Index is an equity index representative of the Japanese…

Performance since series start (in euro) — base 100

22 Mar 20188 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
201920212023202534072326
High 340 (17 Aug 2026) · low 72 (16 Mar 2020) · last 326. Past performance is not indicative of future results.

Returns in euro

1 year+37.8%
3 years+100.7%
5 years+147.8%
10 yearsseries too young
Since series start+226.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)20.28%21.62%19.49%
Max drawdown−11.16%−24.97%−24.97%
Sharpe1.441.030.87
Sortino2.151.451.24
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · JPHG · LU16810393081
RebalixJPHG · LU1681039308 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+28.50%+28.91%−0.41%
2024+24.99%+25.39%−0.40%
2023+33.99%+34.47%−0.49%
2022−2.53%−2.19%−0.34%
2021+11.33%+11.75%−0.42%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 27 Aug 2026 · 37 securities · top-10 weight = 60.5%
Top holdingsWeight
APPLE INC8.9%
ABBVIE INC8.6%
CVS HEALTH CORP8.5%
MICRON TECHNOLOGY INC6.6%
APPLIED MATERIALS INC5.7%
FORTINET INC4.7%
MICROSOFT CORP4.6%
NVIDIA CORP4.5%
JOHNSON & JOHNSON4.4%
META PLATFORMS INC-CLASS A4.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
18MQ · Börse Hamburg, Börse Hannover, Börse München / gettex, Tradegate Exchange
+ 8 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU1681039308/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU1681039308/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU1681039308/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU1681039308
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · JPHG · LU16810393082